RCPT selling unspecified number of shares at unspecified price in underwritten offering: http://finance.yahoo.com/news/receptos-announces-proposed-underwritten-public-200849419.html The share price is +31% since the 6/9/14 announcement on the phase-2 portion of the clinical trial in MS (#msg-103084060).